Indian Pharmaceuticals & Biotech Mid-Large Cap Stocks

Abbott India

Market Cap: ₹586.9b

Operates as a pharmaceutical company in India.

Procter & Gamble Health

Market Cap: ₹98.3b

Manufactures and markets pharmaceuticals and chemical products in India and internationally.

Alembic Pharmaceuticals

Market Cap: ₹163.4b

An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.

Dr. Reddy's Laboratories

Market Cap: ₹1.0t

Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.

Caplin Point Laboratories

Market Cap: ₹189.9b

Engages in the development, production, marketing, and export of generic formulations and branded products in India.

Pfizer

Market Cap: ₹228.3b

Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.

Alkem Laboratories

Market Cap: ₹651.6b

A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.

Sun Pharmaceutical Industries

Market Cap: ₹4.6t

A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.

Cipla

Market Cap: ₹1.2t

Manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.

Jubilant Pharmova

Market Cap: ₹140.5b

Operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally.

Divi's Laboratories

Market Cap: ₹2.3t

Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.

Granules India

Market Cap: ₹212.5b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.

J. B. Chemicals & Pharmaceuticals

Market Cap: ₹387.3b

Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.

Lupin

Market Cap: ₹1.0t

Operates as a pharmaceutical company in India, the United States, and internationally.

Glenmark Pharmaceuticals

Market Cap: ₹654.7b

Develops, manufactures, and sells generics, specialty medicines, and over the counter (OTC) pharmaceutical products in India, North America, Europe, and internationally.

Sanofi Consumer Healthcare India

Market Cap: ₹103.0b

Operates as a fast-moving consumer healthcare company in India.

Marksans Pharma

Market Cap: ₹137.5b

Engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.

NATCO Pharma

Market Cap: ₹170.5b

A pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.

Syngene International

Market Cap: ₹159.8b

A contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally.

Torrent Pharmaceuticals

Market Cap: ₹1.9t

Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally.

Aurobindo Pharma

Market Cap: ₹957.1b

A pharmaceutical company, develops, manufactures, and commercializes generic pharmaceuticals in India, the United States, Europe, and internationally.

Indegene

Market Cap: ₹137.3b

Operates as a digital-first life sciences commercialization company in India, the United States, Europe, North America, and internationally.

Concord Biotech

Market Cap: ₹152.2b

A, biopharma company, engages in the research and development, manufacture, and sale of pharmaceutical products in India and internationally.

Eris Lifesciences

Market Cap: ₹191.3b

Provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.

Ajanta Pharma

Market Cap: ₹451.4b

A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.

Ipca Laboratories

Market Cap: ₹455.7b

An integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹451.4b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

Alivus Life Sciences

Market Cap: ₹168.7b

Develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally.

Gland Pharma

Market Cap: ₹489.5b

Engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.

AstraZeneca Pharma India

Market Cap: ₹194.8b

A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.

CORONA Remedies

Market Cap: ₹129.2b

A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.

Blue Jet Healthcare

Market Cap: ₹112.5b

Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.

Emcure Pharmaceuticals

Market Cap: ₹381.0b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

Anthem Biosciences

Market Cap: ₹492.7b

Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.

Neuland Laboratories

Market Cap: ₹297.9b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

Laurus Labs

Market Cap: ₹999.7b

Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.